Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
Colorcon
Express Scripts
McKesson
Federal Trade Commission
Julphar
Cerilliant
Covington

Generated: June 21, 2018

DrugPatentWatch Database Preview

MEFOXIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Mefoxin patents expire, and when can generic versions of Mefoxin launch?

Mefoxin is a drug marketed by Mylan Institutional and Merck and is included in four NDAs.

The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for MEFOXIN
Drug patent expirations by year for MEFOXIN
Medical Subject Heading (MeSH) Categories for MEFOXIN
Synonyms for MEFOXIN
(6R,7R)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-(aminocarbonyloxymethyl)-7-methoxy-8-oxidanylidene-7-(2-thiophen-2-ylethanoylamino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-{[(aminocarbonyl)oxy]methyl}-7-(methyloxy)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-Carbamoyloxymethyl-7-methoxy-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-4-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6S,7R)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6S,7R)-4-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(thiophen-2-yl)acetamido]-3,4-didehydrocepham-4-carboxylic acid
3-Carbamoyloxymethyl-7-methoxy-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-Carbamoyloxymethyl-7-methoxy-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid anion
3-Carbamoyloxymethyl-7-methoxy-8-oxo-7-(2-thiophen-3-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid anion
35607-66-0
4kow
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, (6R,7S)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7S)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-,(6R,7S)-
607C660
6OEV9DX57Y
73356-24-8
A822898
AB0072765
AC1L9AQF
AJ-45759
AK118716
AKOS022185232
BDBM50335563
BPBio1_000863
BSPBio_000783
BSPBio_003101
C-23881
C06887
CAS-35607-66-0
CC-25581
cefoxitin
Cefoxitin (USAN/INN)
CEFOXITIN SODIUM
Cefoxitina
Cefoxitine
Cefoxitinum
Cefoxotin
ceftoxitin
CEPHOXITIN
CFX
CHEBI:209807
CHEMBL996
D02345
DB01331
DivK1c_000576
DR002637
DSSTox_CID_2764
DSSTox_GSID_22764
DSSTox_RID_76721
DT1586
DTXSID1022764
Epitope ID:116201
FT-0652080
HE337856
IDI1_000576
KB-292901
KBio1_000576
KBio2_001879
KBio2_004447
KBio2_007015
KBio3_002601
KBioGR_000626
KBioSS_001879
Mefoxitin
MFCD00072014
MolPort-006-127-091
NCGC00093351-06
NCGC00183034-01
NINDS_000576
Prestwick0_000832
Prestwick1_000832
Prestwick2_000832
Prestwick3_000832
Rephoxitin
SBI-0051927.P002
SC-65784
SCHEMBL15971
SPBio_000771
SPBio_002704
Spectrum_001399
Spectrum2_000676
Spectrum3_001491
Spectrum4_000153
Spectrum5_001145
ST24046297
Tox21_113009
Tox21_113009_1
UNII-6OEV9DX57Y
WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
ZINC3830449

US Patents and Regulatory Information for MEFOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 062757-001 Jan 8, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-004 Sep 20, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 063182-001 Jan 25, 1993 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Medtronic
QuintilesIMS
McKesson
Federal Trade Commission
Chinese Patent Office
Covington
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.